finnCap - Allergy Therapeutics, Initiation of coverage

finnCap initiate coverage on Allergy Therapeutics, a European specialty pharmaceutical business focused on immunotherapeutic vaccines for the treatment of moderate to severe allergies. It has a profitable underlying European business with growing market share and strong sales growth which finnCap value at 40p per share.

Mark Brewer
Research Director Life Sciences

Company Events - FINNCAP